Aptevo Therapeutics Inc
NASDAQ:APVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
US |
|
H
|
Han Express Co Ltd
KRX:014130
|
KR |
|
N
|
Netskope Inc
NASDAQ:NTSK
|
US |
|
H
|
Hunan Kylinsec Technology Co Ltd
SSE:688152
|
CN |
|
Tambovskaya Energosbytovaya Kompaniya PAO
MOEX:TASB
|
RU |
|
B
|
Blue Cap AG
XETRA:B7E
|
DE |
|
Huang Hsiang Construction Corp
TWSE:2545
|
TW |
|
A
|
Alaska Air Group Inc
DUS:ALK
|
US |
|
Moriya Corp
TSE:1798
|
JP |
|
U
|
Union Materials Corp
KRX:047400
|
KR |
|
K
|
Kansai Food Market Ltd
TSE:9919
|
JP |
|
Chun Yuan Steel Industry Co Ltd
TWSE:2010
|
TW |
|
DIOD PAO
MOEX:DIOD
|
RU |
|
Amadeus Fire AG
LSE:0DK9
|
DE |
|
Cambridge Cognition Holdings PLC
F:1M7
|
UK |
|
GoldON Resources Ltd
XTSX:GLD
|
CA |
|
F
|
Futuristic Solutions Ltd
BSE:534063
|
IN |
Bankruptcy Probability
Aptevo Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptevo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
4.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptevo Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptevo Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
